Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.
Morata L, Cobo J, Fernández-Sampedro M, Guisado Vasco P, Ruano E, Lora-Tamayo J, Sánchez Somolinos M, González Ruano P, Rico Nieto A, Arnaiz A, Estébanez Muñoz M, Jiménez-Mejías ME, Lozano Serrano AB, Múñez E, Rodriguez-Pardo D, Argelich R, Arroyo A, Barbero JM, Cuadra F, Del Arco A, Del Toro MD, Guio L, Jimenez-Beatty D, Lois N, Martin O, Martínez Alvarez RM, Martinez-Marcos FJ, Porras L, Ramírez M, Vergas García J, Soriano A.
Morata L, et al. Among authors: ramirez m.
Antimicrob Agents Chemother. 2019 Apr 25;63(5):e02280-18. doi: 10.1128/AAC.02280-18. Print 2019 May.
Antimicrob Agents Chemother. 2019.
PMID: 30858217
Free PMC article.